The Effect of Masking on Subjective Results During Daily Disposable Contact Lens Studies (ARGON)
This study has been completed.
Sponsor:
CIBA VISION
Information provided by (Responsible Party):
Alcon Research ( CIBA VISION )
ClinicalTrials.gov Identifier:
NCT01155726
First received: June 30, 2010
Last updated: June 26, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to explore the effect of masking on subjective ratings for two daily disposable contact lenses.
| Condition | Intervention |
|---|---|
|
Myopia Hyperopia |
Device: Nelfilcon A contact lens Device: Nelfilcon A contact lens with comfort additive (DACP), unmasked Device: Nelfilcon A contact lens with comfort additive (DACP), masked Device: Nelfilcon A contact lens with comfort additive (DACP), partially masked Device: Etafilcon A contact lens Device: Etafilcon A contact lens with comfort additive (1DAVM), unmasked Device: Etafilcon A contact lens with comfort additive (1DAVM), masked Device: Etafilcon A contact lens with comfort additive (1DAVM), partially masked |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Treatment |
| Official Title: | The Effect of Masking on Subjective Results During Daily Disposable Contact Lens Studies |
Resource links provided by NLM:
Further study details as provided by Alcon Research:
Primary Outcome Measures:
- Average Subjective Comfort [ Time Frame: Insertion, 4 hours, 8 hours each: Day 1, Day 2, and Day 3 ] [ Designated as safety issue: No ]Participants were asked, "How would you rate your comfort with your study lenses?" and indicated their response by marking a continuum line ranging from 0=very poor comfort to 100=excellent comfort. Subjective comfort was collected at three time points (insertion, 4 hours, 8 hours) for 3 days, and the comfort ratings were averaged together.
| Enrollment: | 134 |
| Study Start Date: | May 2010 |
| Study Completion Date: | February 2011 |
| Primary Completion Date: | February 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Nelfilcon A, Masked, Unmasked
Nelfilcon A worn in adaptation phase (bilaterally, 30 days). Period 1: 1DAVM and DACP (masked) worn contralaterally in random assignment for 3 days. Period 2: 1DAVM and DACP (unmasked) worn contralaterally, same assignment, 3 days. All products worn in a daily wear, daily disposable mode.
|
Device: Nelfilcon A contact lens
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.
Other Name: Focus DAILIES®
Device: Nelfilcon A contact lens with comfort additive (DACP), unmasked
Commercially marketed, soft, hydrogel contact lens with comfort additive for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses and removed inserted by participant.
Other Name: DAILIES® AquaComfort Plus®
Device: Nelfilcon A contact lens with comfort additive (DACP), masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.
Other Name: DAILIES® AquaComfort Plus®
Device: Etafilcon A contact lens with comfort additive (1DAVM), unmasked
Commercially marketed, soft, hydrogel contact lens with comfort additive for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.
Other Name: 1-DAY ACUVUE® MOIST®
Device: Etafilcon A contact lens with comfort additive (1DAVM), masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.
Other Name: 1-DAY ACUVUE® MOIST®
|
|
Active Comparator: Nelfilcon A, Masked, Partially Masked
Nelfilcon A worn in adaptation phase (bilaterally, 30 days). Period 1: 1DAVM and DACP (masked) worn contralaterally in random assignment for 3 days. Period 2: 1DAVM and DACP (partially masked) worn contralaterally, same assignment, 3 days. All products worn in a daily wear, daily disposable mode.
|
Device: Nelfilcon A contact lens
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.
Other Name: Focus DAILIES®
Device: Nelfilcon A contact lens with comfort additive (DACP), masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.
Other Name: DAILIES® AquaComfort Plus®
Device: Nelfilcon A contact lens with comfort additive (DACP), partially masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Lens name and manufacturer on blister pack label concealed from participant. Lenses inserted and removed by the participant.
Other Name: DAILIES® AquaComfort Plus®
Device: Etafilcon A contact lens with comfort additive (1DAVM), masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.
Other Name: 1-DAY ACUVUE® MOIST®
Device: Etafilcon A contact lens with comfort additive (1DAVM), partially masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Lens name and manufacturer on blister pack label concealed from participant. Lenses inserted and removed by the participant.
Other Name: 1-DAY ACUVUE® MOIST®
|
|
Active Comparator: Etafilcon A, Masked, Unmasked
Etafilcon A worn in adaptation phase (bilaterally, 30 days). Period 1: 1DAVM and DACP (masked) worn contralaterally in random assignment for 3 days. Period 2: 1DAVM and DACP (unmasked) worn contralaterally, same assignment, 3 days. All products worn in a daily wear, daily disposable mode.
|
Device: Nelfilcon A contact lens with comfort additive (DACP), unmasked
Commercially marketed, soft, hydrogel contact lens with comfort additive for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses and removed inserted by participant.
Other Name: DAILIES® AquaComfort Plus®
Device: Nelfilcon A contact lens with comfort additive (DACP), masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.
Other Name: DAILIES® AquaComfort Plus®
Device: Etafilcon A contact lens
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.
Other Name: 1-DAY ACUVUE®
Device: Etafilcon A contact lens with comfort additive (1DAVM), unmasked
Commercially marketed, soft, hydrogel contact lens with comfort additive for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.
Other Name: 1-DAY ACUVUE® MOIST®
Device: Etafilcon A contact lens with comfort additive (1DAVM), masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.
Other Name: 1-DAY ACUVUE® MOIST®
|
|
Active Comparator: Etafilcon A, Masked, Partially Masked
Etafilcon A worn in adaptation phase (bilaterally, 30 days). Period 1: 1DAVM and DACP (masked) worn contralaterally in random assignment for 3 days. Period 2: 1DAVM and DACP (partially masked) worn contralaterally, same assignment, 3 days. All products worn in a daily wear, daily disposable mode.
|
Device: Nelfilcon A contact lens with comfort additive (DACP), masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.
Other Name: DAILIES® AquaComfort Plus®
Device: Nelfilcon A contact lens with comfort additive (DACP), partially masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Lens name and manufacturer on blister pack label concealed from participant. Lenses inserted and removed by the participant.
Other Name: DAILIES® AquaComfort Plus®
Device: Etafilcon A contact lens
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and lens packaging visible to participant. Lenses inserted and removed by participant.
Other Name: 1-DAY ACUVUE®
Device: Etafilcon A contact lens with comfort additive (1DAVM), masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Blister pack label and packaging not visible to participant. Lenses inserted and removed by the investigator.
Other Name: 1-DAY ACUVUE® MOIST®
Device: Etafilcon A contact lens with comfort additive (1DAVM), partially masked
Commercially marketed, soft, hydrogel contact lens for daily wear, daily disposable use. Lens name and manufacturer on blister pack label concealed from participant. Lenses inserted and removed by the participant.
Other Name: 1-DAY ACUVUE® MOIST®
|
Eligibility| Ages Eligible for Study: | 17 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- 17 years of age or older.
- Ocular exam within 2 years.
- Currently wearing soft contact lenses on a daily wear basis.
- Contact lens prescription between +6.00D and -10.00D.
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Any ocular disease.
- Use of systemic or ocular medications that may affect ocular health.
- Unable to achieve an acceptable fit with the study lenses.
- Anisometropia >1.00D or astigmatism >0.75D.
- Other protocol-defined exclusion criteria may apply.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Alcon Research ( CIBA VISION ) |
| ClinicalTrials.gov Identifier: | NCT01155726 History of Changes |
| Other Study ID Numbers: | P-371-C-101 |
| Study First Received: | June 30, 2010 |
| Results First Received: | February 15, 2012 |
| Last Updated: | June 26, 2012 |
| Health Authority: | Canada: Ethics Review Committee |
Additional relevant MeSH terms:
|
Hyperopia Myopia Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on May 23, 2013